Trailing-twelve-month (TTM) revenue is $50.94 Million with a year-over-year growth of (64.32%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $11,571,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $12,748,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $12,310,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $14,307,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $50,936,000 |
Current P/S: $164,543,521 market capitalization ÷ $50,936,000 TTM revenue = 3.23x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:55:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $14.31M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:55:52.811Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2019-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| License And Service | $0 | N/A | N/A | N/A | N/A | N/A |
| Other | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20192019-12-31 · USD |
|---|---|---|---|---|---|
| Foreign Countries | $3M | N/A | N/A | N/A | N/A |
| Non Us | N/A | $2M | $2M | $2M | $0 |
| U S |
$50.94M
$50.94 Million
(64.32%)
vs. $142.76M a year ago (TTM)
(33.60%)
5 Year compound annual growth rate
1 Year
(64.32%)
3 Year
(34.57%)
5 Year
(33.60%)
10 Year
+1.52%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $42.17M | ($224.79M) | (84.20%) |
| 2024 | $266.96M | +$9.72M | +3.78% |
| 2023 | $257.24M | +$46.20M | +21.89% |
| 2022 | $211.04M | ($115.51M) | (35.37%) |
| 2021 | $326.55M | ($149.27M) | (31.37%) |
| 2020 |
TTM Growth
(64.32%)
3-Year CAGR
(34.57%)
5-Year CAGR
(33.60%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 36 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:55:52.811Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $282,000 |
| $664,000 |
| N/A |
| N/A |
| Product | $356M | N/A | N/A | N/A | $260M | N/A |
|---|
| Product and Service, Other | N/A | N/A | N/A | N/A | $7M | $1M |
|---|
| Product Revenue | N/A | $327M | $211M | $257M | N/A | N/A |
|---|
| $28M |
| $28M |
| N/A |
| N/A |
| N/A |
| UNITED STATES | N/A | N/A | $188M | N/A | $356M |
|---|
| $475.82M |
| +$119.75M |
| +33.63% |
| 2019 | $356.07M | +$354.51M | +22783.74% |
| 2018 | $1.56M | $0 | +0.00% |
| 2017 | $1.56M | ($188.55M) | (99.18%) |
| 2016 | $190.11M | +$160.06M | +532.82% |
